Quantcast

Cancer Drugs May Help Treat Huntington’s

August 23, 2007

Researchers at the University of Leeds say they have made a major breakthrough in the understanding and potential treatment of Huntington’s disease.

The researchers discovered that one of the body’s naturally occurring proteins prevents 57 genes from operating normally in the brains of Huntington’s sufferers.

In addition, the destructive nature of the protein could potentially be halted using drugs that are already being used to treat cancer, reported the study published in the Journal of Neuroscience.

This is a really exciting breakthrough, study leader Dr. Lezanne Ooi said in a statement. It’s early days, but we believe our research could lead to radical changes in treatment for Huntington’s sufferers. The fact that these cancer drugs have already been through the clinical trials process should speed up the time it takes for this research to impact directly on patients.




comments powered by Disqus